Light Emitting Diode (LED) for the Treatment of Wrinkles
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00818246 |
Recruitment Status :
Completed
First Posted : January 7, 2009
Results First Posted : November 16, 2009
Last Update Posted : November 16, 2009
|
Sponsor:
RoseLab Skin Optics Laboratory
Information provided by:
RoseLab Skin Optics Laboratory
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: N/A; Intervention Model: Single Group Assignment; Masking: Single (Outcomes Assessor); Primary Purpose: Treatment |
Conditions |
Skin Aging Photoaging of Skin |
Interventions |
Device: Sham light Device: LumiPhase-R™, OPUSMED Inc. Montreal, Canada |
Enrollment | 40 |
Participant Flow
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | Sham-treated; LED-treated (Split-face Study) |
---|---|
![]() |
one side of the face was treated with a Sham light and the other half with a light emitting diode (LED) at 660 nm three times weekly for four consecutive weeks (12 treatments)on the experimental periorbital area. |
Period Title: Overall Study | |
Started | 40 |
Completed | 35 [1] |
Not Completed | 5 |
Reason Not Completed | |
Impossible to match pictures | 5 |
[1]
split-face study
|
Baseline Characteristics
Arm/Group Title | Sham-treated; LED-treated (Split-face Study) | |
---|---|---|
![]() |
one side of the face was treated with a Sham light and the other half with a light emitting diode (LED) at 660 nm three times weekly for four consecutive weeks (12 treatments)on the experimental periorbital area. | |
Overall Number of Baseline Participants | 40 | |
![]() |
[Not Specified]
|
|
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 40 participants | |
<=18 years |
0 0.0%
|
|
Between 18 and 65 years |
40 100.0%
|
|
>=65 years |
0 0.0%
|
|
Age Continuous
Mean (Standard Deviation) Unit of measure: Years |
||
Number Analyzed | 40 participants | |
45 (7) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 40 participants | |
Female |
37 92.5%
|
|
Male |
3 7.5%
|
|
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||
Canada | Number Analyzed | 40 participants |
40 |
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Results Point of Contact
Name/Title: | Dr Daniel Barolet |
Organization: | RoseLab Skin Optics Laboratory |
Phone: | (514) 343-4444 |
EMail: | daniel.barolet@mcgill.ca |
Responsible Party: | Dr Daniel Barolet, RoseLab Skin Optics Laboratory |
ClinicalTrials.gov Identifier: | NCT00818246 |
Other Study ID Numbers: |
LEDP-1 |
First Submitted: | December 3, 2008 |
First Posted: | January 7, 2009 |
Results First Submitted: | January 7, 2009 |
Results First Posted: | November 16, 2009 |
Last Update Posted: | November 16, 2009 |